
    
      This single-center, randomized, open, single-dose, four-cycle，cross-over design
      bioequivalence test was conducted in subjects after meal conditions. Subjects were fasted for
      at least 10 hours over the night in each cycle，but can't ban their from drinking water.The
      next morning，after eating a high-fat and high-calorie meal for 30 minutes, according to
      test-reference (TR) or Reference-test (RT) sequential oral perindopril tert-butylamine
      tablets (4 mg, 240 mL warm water). Each period was separated with a 14-day wash-out period in
      after meal trials. The blood concentrations of perindopril and perindoprilat in qualified
      subjects were tested. Safety assessment includes vital signs examination, physical
      examination, laboratory safety examination, coagulation examination, electrocardiogram and
      adverse event reports.
    
  